Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 4 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
First Human Death From Bird Flu Puts Vaccine Stocks On The Map - Moderna (NASDAQ:MRNA), CureVac...
Benzinga· 3 days agoVaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
F.D.A. Advisers Recommend a New Covid Vaccine Formula for the Fall
New York Times· 4 days agoA committee of advisers to the Food and Drug Administration voted on Wednesday to update the formula...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 6 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA Today· 4 days agoThe Vaccines and Related Biological Products Advisory Committee – composed of leading U.S. health...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 6 days agoWhen combined with Merck’s Keytruda, the jab has shown improved survival rates and long-lasting...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 6 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
3 Reasons to Buy Moderna Stock | The Motley Fool
The Motley Fool· 1 day agoAlthough Moderna (MRNA -2.38%) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Is Moderna just...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 5 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...